LifeMD Price to Book Ratio 2012-2025 | LFMD
Historical price to book ratio values for LifeMD (LFMD) over the last 10 years. The current price to book ratio for LifeMD as of January 16, 2026 is 53.08.
| LifeMD Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-01-16 | 3.77 | 52.14 | |
| 2025-09-30 | 6.79 | $0.07 | 93.91 |
| 2025-06-30 | 13.62 | $0.01 | 1602.35 |
| 2025-03-31 | 5.44 | $-0.01 | -604.44 |
| 2024-12-31 | 4.95 | $-0.18 | -27.65 |
| 2024-09-30 | 5.24 | $-0.14 | -36.80 |
| 2024-06-30 | 6.86 | $-0.05 | -138.87 |
| 2024-03-31 | 10.28 | $0.03 | 321.25 |
| 2023-12-31 | 8.29 | $0.15 | 56.98 |
| 2023-09-30 | 6.25 | $-0.32 | -19.54 |
| 2023-06-30 | 4.35 | $-0.31 | -13.84 |
| 2023-03-31 | 1.70 | $-0.23 | -7.38 |
| 2022-12-31 | 1.94 | $-0.23 | -8.35 |
| 2022-09-30 | 1.97 | $0.10 | 20.04 |
| 2022-06-30 | 2.04 | $0.22 | 9.25 |
| 2022-03-31 | 3.53 | $0.53 | 6.65 |
| 2021-12-31 | 3.87 | $0.84 | 4.59 |
| 2021-09-30 | 6.21 | $-0.55 | -11.33 |
| 2021-06-30 | 11.78 | $-0.30 | -38.90 |
| 2021-03-31 | 15.82 | $-0.03 | -485.28 |
| 2020-12-31 | 6.53 | $-0.04 | -185.51 |
| 2020-09-30 | 8.25 | $-0.51 | -16.09 |
| 2020-06-30 | 1.50 | $-0.35 | -4.34 |
| 2020-03-31 | 1.05 | $-0.35 | -3.04 |
| 2019-12-31 | 0.60 | $-0.11 | -5.62 |
| 2019-09-30 | 0.85 | $-0.05 | -15.83 |
| 2019-06-30 | 0.55 | $-0.15 | -3.57 |
| 2019-03-31 | 0.75 | $0.02 | 31.25 |
| 2018-12-31 | 0.70 | $0.09 | 7.73 |
| 2018-09-30 | 1.00 | $0.13 | 7.47 |
| 2018-06-30 | 1.10 | $0.15 | 7.20 |
| 2018-03-31 | 1.40 | $0.10 | 13.73 |
| 2017-12-31 | 1.70 | $0.07 | 24.01 |
| 2017-09-30 | 2.15 | $0.06 | 33.54 |
| 2017-06-30 | 1.50 | $-0.05 | -28.14 |
| 2017-03-31 | 2.50 | $-0.16 | -15.19 |
| 2016-12-31 | 1.30 | $-0.05 | -25.34 |
| 2016-09-30 | 1.30 | $0.07 | 19.73 |
| 2016-06-30 | 1.30 | $0.05 | 25.90 |
| 2016-03-31 | 1.50 | $0.03 | 47.02 |
| 2015-12-31 | 0.60 | $0.03 | 21.20 |
| 2015-09-30 | 0.25 | $-0.02 | -11.21 |
| 2015-06-30 | 0.45 | $-0.03 | -16.61 |
| 2015-03-31 | 0.90 | $-0.02 | -40.72 |
| 2014-12-31 | 0.50 | $-0.02 | -22.03 |
| 2014-09-30 | 0.65 | $0.00 | -132.65 |
| 2014-06-30 | 0.70 | $0.00 | 291.67 |
| 2014-03-31 | 1.25 | $0.01 | 91.24 |
| 2013-12-31 | 1.30 | $0.03 | 40.00 |
| 2013-09-30 | 1.30 | $0.01 | 188.41 |
| 2013-06-30 | 1.45 | $0.03 | 47.39 |
| 2013-03-31 | 0.65 | $0.02 | 31.25 |
| 2012-12-31 | 0.80 | $0.02 | 34.33 |
| 2012-09-30 | 0.90 | 0.00 | |
| 2012-06-30 | 0.80 | 0.00 | |
| 2012-03-31 | 0.90 | 0.00 | |
| 2011-12-31 | 1.00 | 0.00 | |
| 2010-12-31 | 1.25 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.181B | $0.212B |
| LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers. LifeMD Inc., formerly known as Conversion Labs, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $166.692B | 30.61 |
| HCA Healthcare (HCA) | United States | $107.089B | 17.73 |
| CVS Health (CVS) | United States | $99.777B | 11.47 |
| Elevance Health (ELV) | United States | $83.311B | 12.22 |
| Cencora (COR) | United States | $68.838B | 22.19 |
| Natera (NTRA) | United States | $31.987B | 0.00 |
| DiDi Global (DIDIY) | China | $23.485B | 21.70 |
| Labcorp Holdings (LH) | United States | $22.455B | 17.12 |
| Medpace Holdings (MEDP) | United States | $17.208B | 42.72 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.445B | 0.00 |
| Viatris (VTRS) | United States | $14.812B | 5.52 |
| BioMerieux (BMXMF) | France | $14.802B | 0.00 |
| ICON (ICLR) | Ireland | $14.747B | 14.63 |
| Solventum (SOLV) | United States | $13.786B | 13.38 |
| Revvity (RVTY) | United States | $12.755B | 23.49 |
| CochLear (CHEOY) | Australia | $11.760B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.813B | 20.82 |
| Avantor (AVTR) | United States | $8.291B | 12.67 |
| Sonic Healthcare (SKHHY) | Australia | $7.752B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.556B | 0.00 |
| HealthEquity (HQY) | United States | $7.294B | 27.27 |
| BrightSpring Health Services (BTSG) | United States | $7.070B | 42.15 |
| Bausch + Lomb (BLCO) | Canada | $6.078B | 39.91 |
| PACS (PACS) | United States | $6.072B | 36.92 |
| Sotera Health (SHC) | United States | $5.449B | 26.27 |
| Alignment Healthcare (ALHC) | United States | $4.502B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.124B | 54.86 |
| Concentras Parent (CON) | United States | $2.762B | 17.24 |
| Organon (OGN) | United States | $2.277B | 2.40 |
| Progyny (PGNY) | United States | $2.114B | 41.56 |
| Surgery Partners (SGRY) | United States | $2.057B | 26.50 |
| Establishment Labs Holdings (ESTA) | United States | $1.962B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.877B | 11.21 |
| Ardent Health (ARDT) | United States | $1.231B | 4.02 |
| Teladoc Health (TDOC) | United States | $1.115B | 0.00 |
| Nutex Health (NUTX) | United States | $1.080B | 8.26 |
| CareDx (CDNA) | United States | $1.029B | 16.82 |
| Omada Health (OMDA) | United States | $0.933B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.910B | 14.89 |
| InnovAge Holding (INNV) | United States | $0.794B | 0.00 |
| Embecta (EMBC) | United States | $0.734B | 4.17 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.706B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.594B | 0.00 |
| CryoPort (CYRX) | United States | $0.552B | 0.00 |
| Enhabit (EHAB) | United States | $0.532B | 23.91 |
| Strata Critical Medical (SRTA) | United States | $0.515B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.445B | 8.19 |
| Agilon Health (AGL) | United States | $0.423B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.343B | 5.51 |
| Oncology Institute (TOI) | United States | $0.330B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.288B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.279B | 58.75 |
| So-Young (SY) | China | $0.269B | 0.00 |
| KindlyMD (NAKA) | United States | $0.201B | 0.00 |
| Beauty Health (SKIN) | United States | $0.191B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.141B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.139B | 0.00 |
| DocGo (DCGO) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.046B | 0.00 |
| Pomdoctor - (POM) | China | $0.030B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.21 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.018B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.016B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |